Call for abstracts
Accepted abstracts will be published in the Journal "Animal - Science Proceedings" https://www.journals.elsevier.com/animal-science-proceedings
Keynotes and Plenary SpeakersKeynotes and Plenary Speakers do not need to use this submission form. They will be directly contacted by the Technical Secretariat to be informed about how to submit the abstract for the corresponding session.
Guidelines for Authors
Please read carefully the instructions detailed below before you start with the online submission process. Failure to observe these guidelines may result in rejection of the submission.
All abstracts must be in English.
According to the topic of your work/case report, please choose the session that you think best describes your submission to ensure adequate evaluation by the scientific committee:
- ISVA Sustainability
General diagnosis to reduce antibiotic usage
Global threat to sheep
Teaching and transfer
- ECSRHM / European College of Small Ruminant Health Management
- SEOC / Sociedad Española de Ovinotecnia y caprinotecnia (Presentations will be in Spanish)
If animal experimentation is part of the study, the work must has met the ethics and animal welfare regulations applicable in the country where the experiments were conducted. There is no need to specify this in the abstract, but the scientific committee may ask for further clarification on this issue if deemed necessary.
Please note that each author can submit a maximum of three contributions as presenting author. Which means that every author may submit and appear as co-author in many abstracts but will be able to appear as presenting author in a maximum of three abstracts.
Commercial names or trademarks cannot be mentioned in the title. However, they will be accepted, in brackets, in the body of the text.
The first step is to enter details for contact person. This person will be the responsible of the submission and will receive all the notifications. Please double check that the contact email is correct.
After that, you will be able to introduce abstract details through the online submission form:
- Type of work (original work or case report)
- Keywords (four)
- Abstract text
- Presentation Preference
Title and authors must not be included together with the body of the abstract. There are special text fields to include this information in the next page of the submission form.
The titles of abstracts should be:
- Concise and informative
- Exclude the name of the country or of the region where the study took place
- Avoid the use of scientific names, if there is a common name
- Do not use non-standard abbreviations.
The abstracts should be structured to include text on:
- Material and Methods (including the any statistical analyses)
- Results and Discussion
- Conclusion and Implications
- References (1 or 2, only if it is essential and for plenary abstracts).
- Acknowledgements and funding (when required)
- Clinical history
- Differential diagnosis,
- References (1 or 2, only if it is essential).
- Acknowledgements and funding (when required)
Due the word limit, abstracts from oral communications/posters or keynotes should not include any Table or Figure. Submissions for plenary talks may include them if the authors consider so.
When data are analyzed by analysis of variance we request that a residual error term such as the pooled standard error, the residual standard deviation (RSD), or the root mean square error (RMSE) is reported in tables and not SE/SD for each treatment. Indeed, anovas are based on the hypothesis of homogeneous variance among treatment groups.
The number of decimals of p-values for means and/or the error term should be homogenized or should follow a systematic rule.
Format of content
- Define non-standard abbreviations at first appearance followed by the abbreviation in brackets.
- Authors should avoid excessive use of non-standard abbreviations.
- Please, so not use non-standard abbreviation in the titles, headings or in the keywords.
- Non-standard abbreviations used in tables and figures must be defined either as footnotes or in the caption.
- Do not start a sentence with an abbreviation.
Presentation of statistical results
- Treatment means are reported with meaningful decimals. For guidance, the last digit of a treatment mean corresponds to 1x10 of standard error (e.g., for a standard error of 1.2, the mean values should be reported as 15)
- In the text, the probability of significance is indicated by the following conventional standard abbreviations (which need not be defined): p > 0.05 for non-significance and p < 0.05, p < 0.01 and p < 0.001 for significance at these levels. Exact level of probability (e.g. p = 0.07) can also be used
Units of measurement
The International System of Units (SI) should be used. A list of units is found at http://physics.nist.gov/cuu/Units/units.html.
References will follow the Animal – Science proceedings journal format. The most recent issue, as an example of format, can be found at https://www.sciencedirect.com/journal/animal-science-proceedings
Keep references to the minimum and only when crucial to introducing or discussing the results
It is the author’s responsibility to ensure that all references are cited and accurate.
For communications and keynotes: the abstract should be a minimum of 400 words and cannot contain more than 450 words of the style sheet.
For Plenaries: the abstract should be a minimum of 1700 words and cannot contain more than 1800 words of the style sheet.
In both cases, excluding title, authors and affiliations.
Once uploaded, you will be able to modify your submission until the deadline. To access again your submission, use email address registered during the initial submission process and the password received in the acknowledgement of receipt.
Please ensure that your abstract does not contain spelling, grammatical or scientific errors. No corrections are possible after the submission deadline. The abstract will be reproduced exactly as submitted. No proof reading will be done.
from 1st June 2022
until 30th November 2022 23:59h (GMT+1)
Authors will be notified about the decision by December 2022.